Galera Therapeutics Inc (GRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Operating Expenses | 13,396 | 16,807 | 13,881 | 13,185 | 12,958 |
| Operating Income | -13,396 | -16,807 | -13,881 | -13,185 | -12,958 |
| Interest Expense | 2,087 | 4,399 | 4,223 | 3,324 | 3,245 |
| Other Income | 410 | 494 | 394 | 251 | 170 |
| Pre-tax Income | -15,073 | -20,712 | -17,710 | -16,258 | -16,033 |
| Net Income Continuous | -15,073 | -20,712 | -17,710 | -16,188 | -16,033 |
| Net Income | $-15,073 | $-20,712 | $-17,710 | $-16,188 | $-16,033 |
| EPS Basic Total Ops | -0.33 | -0.48 | -0.50 | -0.58 | -0.60 |
| EPS Basic Continuous Ops | -0.33 | -0.48 | -0.50 | -0.58 | -0.60 |
| EPS Diluted Total Ops | -0.33 | -0.48 | -0.50 | -0.58 | -0.60 |
| EPS Diluted Continuous Ops | -0.33 | -0.48 | -0.50 | -0.58 | -0.60 |
| EBITDA(a) | $-13,384 | $-16,795 | $-13,861 | $-13,159 | $-12,931 |